Delivery Order SPE2DB22D3010-SPE2DB24FP0RQ
Award Date
10/12/23
Potential Completion Date
10/13/23
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,566,340,622 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $7,873.25 and a period of performance through November 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,991.66, is for the delivery of 4,566,405,648 units of Ondansetron HCl 4 mg Tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,093,192 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The $2,958.33 firm-fixed-price contract has a completion date of December 14, 2023 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This is a $2,665.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,964,524 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,837.81, is for the delivery of 4,567,632,149 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed price and no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,222,794 units of Ondansetron HCL 4 mg tablets, a medication commonly used to prevent nausea and vomiting. The contract has a total ceiling value of $14,687.87 and runs through February 11, 2025. This contract is not designated as a set-aside contract. AmerisourceBergen holds...
This is a $1,167.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,149,344 units of the prescription medication Ondansetron ODT 4 mg Tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...